MedTrace Logo

Italian Observational Study on CAR-T Therapy for Lymphoma

NCT06339255 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5300

Last updated 2024-04-01

No results posted yet for this study

Summary

The goal of this observational study on chimeric antigen receptor T-cell therapy is to monitor the feasibility, efficacy, toxicity and biomarkers in a real life setting.

Partecipants will be asked to agree to their clinical data collection and to partecipate to the optional biological study that aims to evaluate biomarkers of toxicity and response (clinical characteristics, cytokine profile, cellcomposition and type of the CAR-T cell product, lymphoma genomics). The study will evaluate even the disease response according to lugano criteria by PET and CT in routine clinical activity.

Conditions

Sponsors & Collaborators

  • Annalisa Chiappella

    collaborator UNKNOWN

  • Cristiana Carniti

    collaborator UNKNOWN

  • Anna Dodero

    collaborator UNKNOWN

  • Paolo Corradini

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06339255 on ClinicalTrials.gov